A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

Condition:   Acute Myeloid Leukemia and Myelodysplastic Syndrome Intervention:   Drug: QLF32101 Sponsor:   Qilu Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials